BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2021 1:47:10 PM | Browse: 851 | Download: 2470
Publication Name World Journal of Diabetes
Manuscript ID 63242
Country India
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Review
Article Title Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus
Manuscript Source Invited Manuscript
All Author List Rajan Palui, Subhodip Pramanik, Sunetra Mondal and Sayantan Ray
ORCID
Author(s) ORCID Number
Rajan Palui http://orcid.org/0000-0002-2429-3595
Subhodip Pramanik http://orcid.org/0000-0002-3196-1192
Sunetra Mondal http://orcid.org/0000-0003-3064-466X
Sayantan Ray http://orcid.org/0000-0002-6274-465X
Funding Agency and Grant Number
Corresponding Author Sayantan Ray, MBBS, MD, Doctor, Doctor, Department of Endocrinology, Medica Superspeciality Hospital and Medica Clinic, 127, EM Bypass, Mukundapur, Kolkata 700099, West Bengal, India. sayantan.ray30@gmail.com
Key Words Diabetes; Fracture risk; Bone mineral density; Microarchitecture; Anti-diabetic drugs; Anti-osteoporosis therapy
Core Tip Diabetes mellitus, either type 1 or type 2, has adverse effects on bone that translate into an elevated fracture risk. Different pathophysiological mechanisms contribute to poor bone health in patients with diabetes. Diagnosis of bone fragility in diabetic patients is challenging as traditional fracture predictors underestimate fracture risk in this population, contributing to the concept that diabetes affects bone quality. While waiting for further evidence, the prevention and management of bone fragility in diabetes should include identification of patients at risk, correction of modifiable risk factors, appropriate choice of anti-diabetic medications, and use of anti-osteoporosis drugs with proven efficacy.
Publish Date 2021-06-04 13:47
Citation Palui R, Pramanik S, Mondal S, Ray S. Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus. World J Diabetes 2021; 12(6): 706-729
URL https://www.wjgnet.com/1948-9358/full/v12/i6/706.htm
DOI https://dx.doi.org/10.4239/wjd.v12.i6.706
Full Article (PDF) WJD-12-706.pdf
Full Article (Word) WJD-12-706.docx